Back

Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines - LGE remains tough to beat

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging Late Gadolinium Enhancement ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rita Amador

Hospital Santa Cruz, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail
Incremental prognostic value of late gadolinium enhancement granularity in patients with hypertrophic cardiomyopathy
Mr J. Florence (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Left atrioventricular coupling index is an independent associate of new-onset AF and stroke in hypertrophic cardiomyopathy: a CMR study
Doctor M. De Raffele (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
CMR-derived pulmonary artery to aorta ratio as a predictor of adverse outcome in patients with cardiac transthyretin amyloidosis
Doctor C. Kronberger (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy
Doctor J. Wang (Chengdu, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impact of various iron deficiency definitions on mortality risk in chronic heart failure across the spectrum of left ventricular ejection fraction spectrum.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources